Tokyo, Jan. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060279) titled 'A multicenter retrospective observational study of patients with generalized myasthenia gravis treated with efgartigimod' on Jan. 7.
Study Type:
Observational
Primary Sponsor:
Institute - argenx Japan K.K.
Condition:
Condition - generalized myasthenia gravis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To describe the medical history of patients with generalized myasthenia gravis (gMG) treated with efgartigimod, including the treatment history of gMG, symptoms of gMG, and adverse events before and after efgartigimod treatment. This study will use a post-marketin...